June 09, 2010
UltraShape Ltd. recently announced that the US Food and Drug Administration advised the company that it may submit a request for clearance of its Contour I system under the 510(k) regulation rather than as a Pre-Market Approval (PMA) as was previously advised which should shorten the FDA clearance process